R. Cavalcanti

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program

A. Loupy, L. Lamhaut, C. Suberbielle, 2017, Transplantation.

Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study

E. Thervet, F. Martinez, C. Legendre, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact and evolution of peliosis hepatis in renal transplant recipients.

F. Carnot, C. Degott, C. Legendre, 1994, Transplantation.

Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study.

E. Thervet, C. Legendre, S. Pol, 1994, Transplantation.

Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.

F. Carnot, C. Bréchot, E. Thervet, 1996, Transplantation.

Randomized trial of early corticosteroid reduction vs. regular‐dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: the Brazilian CORRETA trial

M. Abbud-Filho, V. Garcia, R. T. Gonçalves, 2010, Clinical transplantation.